Yüklüyor......
Relapsing-Remitting Multiple Sclerosis Patients' Experience with Natalizumab: A Phenomenological Investigation
This phenomenological investigation was undertaken to gain a better understanding of multiple sclerosis (MS) patients' experience with natalizumab (Tysabri; Biogen Idec Inc, Cambridge, MA) treatment and its impact on their quality of life (QOL). Twenty MS patients who were receiving natalizumab...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Consortium of Multiple Sclerosis Centers
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3882975/ https://ncbi.nlm.nih.gov/pubmed/24453731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073-14.1.39 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|